FDA Approved: DOCETAXEL — Supplemental Application (Gland Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for docetaxel from Gland Pharma Limited under an ANDA for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

SUPPL AP for DOCETAXEL (DOCETAXEL)